A prior study by Mark et al. identified that thecathelicidin-derived peptide LL-37 (Table 1), which is produced by cleaving the humancationic antimicrobial peptide-18 (hCAP-18) encoded by CAMP, was effectiveagainst leishmaniasis. This evidence concerns the gene CAMP and leishmaniasis.